Sampatkumarr Govind Donthula

Mar 18, 2025 | outsourcedpharma.com | Sampatkumarr Govind Donthula |Marketsand Markets |Louis Garguilo

Guest Column | March 18, 2025 By Sampatkumarr Govind Donthula, MarketsandMarkets Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone that stimulates insulin secretion, gene expression, and ß-cell proliferation. The U.S. FDA has approved dipeptidyl peptidase-4 (DPP-IV) resistant long-acting GLP-1s as injectable drugs for treating patients with type 2 diabetes.